Pandemic control practices cut healthcare-acquired infections
Oct 18, 2023
A reduction also was seen in nosocomial respiratory viral infections.
Healthcare-associated infections higher for patients hospitalized with COVID-19
Apr 14, 2023
The findings were seen for central line-associated bloodstream infection, catheter-associated urinary tract infection and methicillin-resistant Staphylococcus aureus bacteremia.
Big senior living stories of 2023
By
Lois A. Bowers
Dec 21, 2023
The long shadow of the pandemic continued to recede in 2023, although the senior living profession continued to feel its effects. The COVID-19 public emergency ended May 11. Wage growth has declined but...
NIH investigating COVID-19 experiments conducted at Boston University
Oct 19, 2022
The US National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a “killer”...
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
WHO chief sounds alarm on bird flu circulating in US cattle
Apr 22, 2024
The H5N1 avian flu virus that’s infecting US cattle is increasingly showing up in mammals — a dangerous sign that it could someday easily infect people.
FDA warns of counterfeit Lumify eye drops hitting the market
Feb 01, 2024
Use of the counterfeit products could lead to an antibiotic-resistant infection.
US will make millions of bird flu vaccines this summer
Jun 03, 2024
As the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans.
Long-term smell, but not taste, deficits seen after COVID-19
May 01, 2024
The deficits appear to be the greatest for individuals with the original untyped and alpha variant infections.
Seroprevalence to SARS-CoV-2 has increased over time
Nov 17, 2022
The global seroprevalence from infection or vaccination reached 59.2% by September 2021.